We are live on ! Find out more
HURA

TuHURA Biosciences

24 hedge funds and large institutions have $6.31M invested in TuHURA Biosciences in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 2

75% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 4

60% more capital invested

Capital invested by funds: $3.95M → $6.31M (+$2.36M)

14% more funds holding

Funds holding: 2124 (+3)

0% more ownership

Funds ownership: 0%0% (+0%)

Holders
24
Holders Change
+3
Holders Change %
+14.29%
% of All Funds
0.42%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
7
Reduced
2
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
26
Renaissance Technologies
New York
-$81K -27 Closed
TSS
27
Two Sigma Securities
New York
-$21K -7 Closed
FNB
28
Farmers National Bank
Kentucky
-$19.6K -6 Closed
SFS
29
Sowell Financial Services
Arkansas
-$10K -5 Closed

HURA Hedge Fund Activity: Q2 2021 in Review

24 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q2 2021, worth a combined $6.31M — up 60% from $3.95M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new HURA positions and 4 closed out — a net gain of 3 holders — while 7 added to existing stakes and 2 trimmed.

The largest buyer was Vanguard Group, adding an estimated $922K. The largest seller was Nantahala Capital Management, cutting an estimated $623K.

  • 24 institutional investors held TuHURA Biosciences (HURA) as of Q2 2021, up from 21 in Q1 2021.
  • Funds reported $6.31M of TuHURA Biosciences stock for Q2 2021, up 60% quarter-over-quarter.
  • 7 funds opened new TuHURA Biosciences positions in Q2 2021 and 4 closed out, a net change of +3 holders.
  • The largest TuHURA Biosciences buyer in Q2 2021 was Vanguard Group, an estimated $922K added.
  • The largest TuHURA Biosciences seller in Q2 2021 was Nantahala Capital Management, an estimated $623K sold.

Based on aggregated 13F filings for Q2 2021.